List of Moxatag drug patents

Moxatag is owned by Pragma.

Moxatag contains Amoxicillin.

Moxatag has a total of 3 drug patents out of which 0 drug patents have expired.

Moxatag was authorised for market use on 23 January, 2008.

Moxatag is available in tablet, extended release;oral dosage forms.

Moxatag can be used as use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes, method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in a once-a-day amoxicillin product.

The generics of Moxatag are possible to be released after 07 May, 2027.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8778924 PRAGMA Modified release amoxicillin products
Dec, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8357394 PRAGMA Compositions and methods for improved efficacy of penicillin-type antibiotics
Dec, 2026

(3 years from now)

US8299052 PRAGMA Pharmaceutical compositions and methods for improved bacterial eradication
May, 2027

(4 years from now)

Drugs and Companies using AMOXICILLIN ingredient

Market Authorisation Date: 23 January, 2008

Treatment: Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes; Method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in a once-a-day amoxicillin product

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic